Literature DB >> 23269122

New insight into the pathogenesis of retinopathy of prematurity: assessment of whole-genome expression.

Jacek J Pietrzyk1, Przemko Kwinta, Mirosław Bik-Multanowski, Anna Madetko-Talowska, Mateusz Jagła, Tomasz Tomasik, Zofia Mitkowska, Embjørg J Wollen, Ståle Nygård, Ola D Saugstad.   

Abstract

BACKGROUND: Retinopathy of prematurity (ROP) is one of the most common preventable causes of blindness and impaired vision among children in developed countries. The aim of the study was to compare whole-genome expression in the first month of life in groups of infants with and without ROP.
METHODS: Blood samples were drawn from 111 newborns with a mean gestational age of 27.8 wk on the 5th, 14th, and 28th day of life (DOL). The mRNA samples were evaluated for gene expression with the use of human whole-genome microarrays. The infants were divided into two groups: no ROP (n = 61) and ROP (n = 50).
RESULTS: Overall, 794 genes were differentially expressed on the 5th DOL, 1,077 on the 14th DOL, and 3,223 on the 28th DOL. In each of the three time points during the first month of life, more genes were underexpressed than overexpressed in the ROP group. Fold change (FC), which was used in analysis of gene expression data, ranged between 1.0 and 1.5 in the majority of genes differentially expressed.
CONCLUSION: Pathway enrichment analysis revealed that genes in four pathways related to inflammatory response were consistently downregulated due to the following variables: ROP and gestational age.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23269122     DOI: 10.1038/pr.2012.195

Source DB:  PubMed          Journal:  Pediatr Res        ISSN: 0031-3998            Impact factor:   3.756


  7 in total

Review 1.  Retinopathy of prematurity: contribution of inflammatory and genetic factors.

Authors:  Mariza Fevereiro-Martins; Hercília Guimarães; Carlos Marques-Neves; Manuel Bicho
Journal:  Mol Cell Biochem       Date:  2022-03-09       Impact factor: 3.396

2.  Genetic and Environmental Influences on Retinopathy of Prematurity.

Authors:  J M Ortega-Molina; R Anaya-Alaminos; J Uberos-Fernández; A Solans-Pérez de Larraya; M J Chaves-Samaniego; A Salgado-Miranda; R Piñar-Molina; A Jerez-Calero; J L García-Serrano
Journal:  Mediators Inflamm       Date:  2015-05-21       Impact factor: 4.711

3.  Development and maturation of the immune system in preterm neonates: results from a whole genome expression study.

Authors:  Magdalena Zasada; Przemko Kwinta; Wojciech Durlak; Mirosław Bik-Multanowski; Anna Madetko-Talowska; Jacek Józef Pietrzyk
Journal:  Biomed Res Int       Date:  2014-05-28       Impact factor: 3.411

4.  Gene expression profiles in preterm infants on continuous long‑term oxygen therapy suggest reduced oxidative stress‑dependent signaling during hypoxia.

Authors:  Betty Kalikstad; Hanna Göransson Kultima; Terese Kristoffersen Andersstuen; Arne Klungland; Anders Isaksson
Journal:  Mol Med Rep       Date:  2017-02-08       Impact factor: 2.952

5.  Short- and long-term impact of hyperoxia on the blood and retinal cells' transcriptome in a mouse model of oxygen-induced retinopathy.

Authors:  Magdalena Zasada; Anna Madetko-Talowska; Cecilie Revhaug; Anne Gro W Rognlien; Lars O Baumbusch; Teofila Książek; Katarzyna Szewczyk; Agnieszka Grabowska; Miroslaw Bik-Multanowski; Jacek Józef Pietrzyk; Przemko Kwinta; Ola Didrik Saugstad
Journal:  Pediatr Res       Date:  2019-10-02       Impact factor: 3.756

6.  Differential systemic gene expression profile in patients with diabetic macular edema: responders versus nonresponders to standard treatment.

Authors:  Supriya S Dabir; Debashish Das; Jeyabalan Nallathambi; Shwetha Mangalesh; Naresh Kumar Yadav; Jan S A G Schouten
Journal:  Indian J Ophthalmol       Date:  2014-01       Impact factor: 1.848

7.  Identification of Iron Homeostasis Genes Dysregulation Potentially Involved in Retinopathy of Prematurity Pathogenicity by Microarray Analysis.

Authors:  Xian-Qiong Luo; Chun-Yi Zhang; Jia-Wen Zhang; Jing-Bo Jiang; Ai-Hua Yin; Li Guo; Chuan Nie; Xu-Zai Lu; Hua Deng; Liang Zhang
Journal:  J Ophthalmol       Date:  2015-10-18       Impact factor: 1.909

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.